Evidence map›Paper›PMID 29378723›Full record

ArticleAntimicrobial agents and chemotherapy2018

Emergence and Spread of

Theerayot Kobasa, Eldin Talundzic, Rungniran Sug-Aram, Patcharida Boondat, Ira F Goldman, Naomi W Lucchi, Pratin Dharmarak, David Sintasath, Mark Fukuda, Toni Whistler and 4 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Global assessment of partial artemisinin resistance: multicenter trial across Kenya, Peru, and Thailand in patients with uncomplicated Plasmodium falciparum malaria.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Uncovering the antimalarial potential of toad venoms through a bioassay-guided fractionation process.International journal for parasitology. Drugs and drug resistance · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook.International journal for parasitology. Drugs and drug resistance · 2021
    Article
  16. Article
  17. Article
  18. Origin and Spread of Evolving Artemisinin-ResistantThe American journal of tropical medicine and hygiene · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Theerayot Kobasa *Bureau of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health (MOPH), Nonathaburi, Thailand.
Eldin Talundzic *Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA etalundzic@cdc.gov.
Rungniran Sug-AramBureau of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health (MOPH), Nonathaburi, Thailand.
Patcharida BoondatMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Ira F GoldmanMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Naomi W LucchiMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pratin DharmarakU.S. President's Malaria Initiative, USAID/RDMA, Bangkok, Thailand.
David SintasathU.S. President's Malaria Initiative, USAID/RDMA, Bangkok, Thailand.
Mark FukudaU.S. President's Malaria Initiative, USAID/RDMA, Bangkok, Thailand.
Toni WhistlerThailand Ministry of Public Health (MOPH)-U.S. CDC Collaboration, Nonathaburi, Thailand.ORCID 0000-0002-7250-908X
John MacArthurThailand Ministry of Public Health (MOPH)-U.S. CDC Collaboration, Nonathaburi, Thailand.
Venkatachalam UdhayakumarMalaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Preecha PrempreeBureau of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health (MOPH), Nonathaburi, Thailand.
Nipon ChinanonwaitBureau of Vector Borne Diseases, Department of Disease Control, Ministry of Public Health (MOPH), Nonathaburi, Thailand.
Ministry of Public Health · THCenters for Disease Control and Prevention · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artemisinin-based combination therapy (ACT) is the most effective and widely used treatment for uncomplicated

Indexed as

AntimalarialsArtemisininsGenotypeHumansMutationPlasmodium falciparumThailandAntimalarialsartemisininArtemisininsartemisinin resistancekelch13kelch13 mutationsmalaria drug resistancemolecular surveillancePlasmodium falciparum drug resistanceThailand

Identifiers

PMID29378723
PMCPMC5914000
OpenAlexW2789297352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.